Humoral immune markers and their association with the psychoemotional state of patients with systemic lupus erythematosus

Authors

  • Yusimí González Álvarez Hospital Clínico-Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara
  • Lutgarda Pérez de Alejo Rodríguez Hospital Clínico-Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara
  • Alain León Medina Hospital Clínico-Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara
  • Carmen Xiomara Moré Chang Dirección Municipal de Salud, Santa Clara, Villa Clara
  • Adialys Alemán Zamora Hospital Clínico-Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara

Keywords:

systemic lupus erythematosus, biomarkers, autoinmune inflammatory diseases, psychoemotional state.

Abstract

A descriptive and cross-sectional investigation of 154 patients, aged 20 to 59, with systemic lupus erythematosus assisted in the Autoinmune Diseases Provincial Service of "Arnaldo Milián Castro" Clinical Surgical Hospital in Santa Clara (Villa Clara), was carried out from June, 2014, to May, 2015, aimed at determining the association of the humoral immune markers with the psychoemotional state, as predictive factors of decompensating events in these affected patients.  In the series, there was a prevalence of the young adults, female sex, white color of the skin, workers as occupation, hypertension as personal pathological history and coffeeholism.  At the same time, the detected disorders constituted humoral immune and inflammatory markers to predict possible activity of the disease in the subclinical stage and it was strongly associated with the presence of emotional disorders (anxiety and depression) in the patient, what can suggest an imminent future acute crisis of the disease.

Downloads

Download data is not yet available.

References

1. Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011; 365(22): 2110-21.

2. Grupo de Trabajo de la Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico. Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico. Canarias: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2015 [citado 12 Feb 2017]. Disponible en: http://www.guiasalud.es/GPC/GPC_549_Lupus_SESCS_compl.pdf

3. Ugarte Gil MF, Acevedo Vásquez E, Alarcón GS, Pastor Asurza C, Alfaro Lozano JL, Cucho Venegas JM, et al. The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort. Ann Rheum Dis. 2015; 74(6): 1019-23.

4. Enríquez-Mejía MG. Fisiopatología del lupus eritematoso sistémico. Rev Med Invest. 2013; 1(1):8-16.

5. Sciascia S, Bertolaccini ML, Baldovino S, Roccatello D, Khamashta MA, Sanna G. Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria. Autoimmun Rev. 2013; 12(3): 426–9.

6. Ekblom Kullberg S, Kautiainen H, Alha P, Leirisalo-Repo M, Miettinen A, Julkunen H. Smoking, disease activity, permanent damage and dsDNA autoantibody production in patients with systemic lupus erythematosus. Rheumatol Int. 2014; 34(3): 341–5.

7. Cohen D, Berger SP, Steup-Beekman GM, Bloemenkamp KW, Bajema IM. Diagnosis and management of the antiphospholipid syndrome. BMJ. 2010; 340: 2541.

8. Pérez Mesa YE, Otero Ramos I. Calidad de vida, ansiedad, depresión y optimismo disposicional en pacientes con lupus eritematoso sistémico. Psicogente. 2014 [citado 12 Feb 2017]; 17(31). Disponible en: http://revistas.unisimon.edu.co/index.php/psicogente/article/view/1473

9. Schur PH, Hahn BH. Epidemiology and pathogenesis of systemic lupus erythematosus. UpToDate. 2011 [citado 12 Feb 2017]. Disponible en: http://cursoenarm.net/UPTODATE/contents/mobipreview.htm?38/19/39217

10. Grimaldi CM. Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells. Curr Opin Rheumatol. 2006; 18(5):456-61.

11. Conrad K, Mehlhorn J, Lüthke K, Dörner T, Frank KH. Systemic lupus erythematosus after heavy exposure to quartz dust in uranium mines: clinical and serological characteristics. Lupus. 1996; 5(1) 62-9.

12. Furtado J, Isenberg DA. B cell elimination in systemic lupus erythematosus. Clin Immunol. 2013; 146(2): 90-103.

13. Mok CC, Kwok CL, Ho LY, Chan PT, Yip SF. Life expectancy, standarized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. Arthritis Rheum. 2011; 63(5): 1182-9.

14. Bertsias G, Cervera R, Boumpas DT, D´Cruz D. Systemic lupus erythematosus: pathogenesis and clinical features. EULAR. 2012 [citado 12 Feb 2017]; 20: 476-505. Disponible en: https://pdfs.semanticscholar.org/1f97/be39612ef14f62ca880ec35fdad2df75823e.pdf?_ga=2.200203630.1912483324.1508340979-339780031.1508340979

Downloads

Published

2017-11-09

How to Cite

1.
González Álvarez Y, Pérez de Alejo Rodríguez L, León Medina A, Moré Chang CX, Alemán Zamora A. Humoral immune markers and their association with the psychoemotional state of patients with systemic lupus erythematosus. MEDISAN [Internet]. 2017 Nov. 9 [cited 2025 Jun. 2];21(11). Available from: https://medisan.sld.cu/index.php/san/article/view/1796

Issue

Vol. 21 No. 11 (2017): MEDISAN

Section

Original Articles

License

All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.